ClinVar Miner

Submissions for variant NM_000350.3(ABCA4):c.4538A>G (p.Gln1513Arg)

gnomAD frequency: 0.00002  dbSNP: rs281865402
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Blueprint Genetics RCV000505160 SCV001241136 likely pathogenic Retinal dystrophy 2018-11-16 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000085646 SCV001248241 pathogenic not provided 2018-09-01 criteria provided, single submitter clinical testing
Invitae RCV000085646 SCV001388934 pathogenic not provided 2023-12-11 criteria provided, single submitter clinical testing This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 1513 of the ABCA4 protein (p.Gln1513Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with retinal disease (PMID: 28559085, 29925512; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99293). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Ocular Genomics Institute, Massachusetts Eye and Ear RCV001376334 SCV001573444 likely pathogenic Severe early-childhood-onset retinal dystrophy 2021-04-08 criteria provided, single submitter research The ABCA4 c.4538A>G variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PM3, PS3. Based on this evidence we have classified this variant as Likely Pathogenic.
Retina International RCV000085646 SCV000117785 not provided not provided no assertion provided not provided
Eurofins Ntd Llc (ga) RCV000085646 SCV000202090 uncertain significance not provided 2013-12-17 flagged submission clinical testing
NIHR Bioresource Rare Diseases, University of Cambridge RCV000505160 SCV000598980 likely pathogenic Retinal dystrophy 2015-01-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.